All Stories

  1. An integrated NMR and DFT study on the conformational preferences of N-alkyl benzamides
  2. Modulating Luminescence Thermometry of the Eu III /Tb III Pair in Coordination Polymers through Ligand Structure and Lanthanide(III) Molar Ratio
  3. A serendipitous product of the reaction of famotidine with copper(II)
  4. Structural, supramolecular analysis, and photoluminescence properties of a new hydroxybenzohydrazide Schiff base
  5. Copper(II)-5-chloro-2-hydroxybenzophenone Complexes with N – N Donors: Structural Insights and Antitumor Activity against A2780 Human Ovarian Cancer Cells of ...
  6. An integrated NMR and DFT study on the conformational preferences of N-alkyl benzamides
  7. Para -substituted benzoic acid ruthenium( ii ) complexes: structural features modulating cytotoxicity
  8. Elucidating thermally activated luminescence quenching in Eu III β-diketonate complexes as crystals or polymeric films for application in thermometry
  9. Antiproliferative activities in vitro of novel palladium(II) indole thiosemicarbazones complexes and Molecular Docking Studies with DNA
  10. Positional Effects of the N-pyridyl Atom on Crystal Packing, Docking and Electronic Properties of Chalcone‑Based HydrazonesPositional Effects of the N-pyridyl Atom on Crystal Packing, Docking and Electronic Properties of Chalcone‑Based Hydrazones
  11. Manganese‐Induced Production of Antioxidant Polyene Steroids in the Extremophile Fungus Talaromyces fuscoviridis Isolated From Copper‐Mine Soil
  12. New Naphthoquinone‐Based Manganese (II) Complexes: Synthesis, Characterization, and Cytotoxicity
  13. Use of computational techniques in Raman spectra analysis
  14. Ascorbyl Radicals as Reducing Agents in Copper-Catalyzed Redox Reactions
  15. The Vortex-Slurry Implementation: A Cheap, Easy, and Ultrafast Mechanochemical Tool to Synthesize/Screen Pharmaceutical Salts and Cocrystals
  16. A supersaturated glass-melt approach for growing micrometer-sized TGG single crystals
  17. Enhanced Anticancer Potential of Pd(II)-Thiosemicarbazone Complexes: Selectivity, Mechanisms, and 3D Models
  18. Innovative synthesis of Tm³⁺/Er³⁺-doped Yb-YGG single crystals for upconversion-based white light emission
  19. Ru(II)-Fenamic-Based Complexes as Promising Human Ovarian Antitumor Agents: DNA Interaction, Cellular Uptake, and Three-Dimensional Spheroid Models
  20. A new anthelmintic salt
  21. Enhancing physicochemical properties of hydrochlorothiazide with zwitterionic L-proline and 5-fluorocytosine cocrystals through mechanochemical synthesis
  22. Ruthenium(II) Complex with 1-Hydroxy-9,10-Anthraquinone Inhibits Cell Cycle Progression at G0/G1 and Induces Apoptosis in Melanoma Cells
  23. A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization—explanation of its folded conformation
  24. A nickel glutamate metal biomolecule framework
  25. Dual spectral and temporal encoding in luminescent polymeric films using a EuIII complex and a persistent phosphor for anti-counterfeiting applications
  26. Reactions of ketosulfoxonium ylides with allylic carbocations: stereoselective and direct access to highly-substituted cyclo-propanes and α-alkylated ylides
  27. Diastereoselective Synthesis of Highly Functionalized γ‐Lactams via Ugi Reaction/Michael Addition
  28. A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate
  29. NMR and X-ray diffraction conformational study of guanidines
  30. Synthesis, XRD structural analysis and theoretical studies of a potential inhibitor against rheumatoid arthritis (RA)
  31. Reactivity of the p‐Cymene‐Ruthenium Complex with Two Phenylamines for Metathesis Polymerization of Norbornene Compared to the Reactivity of Complexes with a Single Benzylamine or Dibenzylamine
  32. Structural Properties and Charge Redistribution in Cocrystallized Pharmaceutical Ingredients: A Comparative Experimental and Theoretical Charge Density Analysis
  33. Synthesis, characterization and structural analysis of complexes from 2,2′:6′,2′′-terpyridine derivatives with transition metals
  34. Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method
  35. Study of the Conformation of Bromated Guanidines with Potential Anti-leishmania Activity
  36. Use of Mechanochemical Methodology to Explore the Formation of a New Crystalline Phase in the Curcumin‐Quercetin System
  37. Intensity and lifetime ratiometric luminescent thermometer based on a Tb(iii) coordination polymer
  38. Versatile Applications of Cyanoacetic Acid in Organic Chemistry: Active Methylene Compound for the Knoevenagel Condensation and Organocatalyst for the Biginelli Reaction
  39. Structural and Anticancer Studies of Methoxyflavone Derivative from Strychnos pseudoquina A.St.-Hil. (Loganiaceae) from Brazilian Cerrado
  40. Synthesis, Characterization, DNA Binding and Cytotoxicity of Copper(II) Phenylcarboxylate Complexes
  41. Synthesis, Characterization and Structural Analysis of Two New Biguanide Complexes
  42. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution
  43. Nitrosyl/Diphenylphosphine/Amino Acid–Ruthenium Complexes as Inhibitors of MDA-MB-231 Breast Cancer Cells
  44. Molecular structure of Ru(II)/diphosphine/4,6-dimethyl-2-pyrimidinethiol complexes: A combined experimental and density functional theory study
  45. Drug Repurposing of the Antiviral Drug Acyclovir: New Pharmaceutical Salts
  46. Development of Copper Complexes with Diimines and Dipicolinate as Anticancer Cytotoxic Agents
  47. “Half-Sandwich” Ruthenium Complexes with Alizarin as Anticancer Agents: In Vitro and In Vivo Studies
  48. Tuning the Thermometric Features in 1D Luminescent EuIII and TbIII Coordination Polymers through Different Bridge Phosphine Oxide Ligands
  49. It Takes Two to Tango, Part II: Synthesis of A-Ring Functionalised Quinones Containing Two Redox-Active Centres with Antitumour Activities
  50. New Copper(II)-L-Dipeptide-Bathophenanthroline Complexes as Potential Anticancer Agents—Synthesis, Characterization and Cytotoxicity Studies—And Comparative DNA-Binding Study of Related Phen Complexes
  51. Spontaneous Resolution of RS-Fluoxetine to a Racemic Conglomerate upon Salt Formation with Oxalic Acid
  52. Activation–Deactivation of Inter-Peptide Bond in Fluoro-N-(2-hydroxy-5-methyl phenyl)benzamide Isomers, Induced by the Position of the Halogen Atom in the Benzene Ring
  53. Highlighting Recent Crystalline Engineering Aspects of Luminescent Coordination Polymers Based on F-Elements and Ditopic Aliphatic Ligands
  54. Synthesis and Evaluation of Antibacterial Activity of 1,2,3-Triazole and Ether Derivatives of Paeonol
  55. The Nicotinamide Ruthenium(II) Complex Induces the Production of Reactive Oxygen Species (ROS), Cell Cycle Arrest, and Apoptosis in Melanoma Cells
  56. Roméite-Group Minerals Review: New Crystal Chemical and Raman Data of Fluorcalcioroméite and Hydroxycalcioroméite
  57. Vibrational and conformational analysis of structural phase transition in Estradiol 17β valerate with temperature
  58. Estudio estructural y supramolecular del ácido 2-E-((4-hidroxifenil) diazenil) benzoico
  59. Crystal Engineering in the design of New Solid Pharmaceutical Forms with enhanced pharmaceutical properties
  60. Amino–Imino Tautomerism in the Salt Formation of Albendazole: Hydrobromide and Nitrate Salts
  61. Glycosylated narciclasine alkaloid in Hippeastrum puniceum (Lam.) Kuntze
  62. Synthesis and X-ray crystal structures of polyfunctionalized 4H-chromene derivatives via tricomponent reaction with Knoevenagel adducts as intermediates in aqueous medium
  63. Molecular Structure Studies on Allyl Sulfonamides: Synthesis, Theoretical Treatment and Evaluation of Biological Activity
  64. meso-Tetra-(4-pyridyl)porphyrin/palladium(ii) complexes as anticancer agents
  65. Study of secondary porosity by SAXS and N 2 adsorption in composite materials obtained from a Cuban natural clinoptilolite
  66. Silver complexes with fluoroanthranilic acid isomers: Spectroscopic characterization, antimycobacterial activity and cytotoxic studies over a panel of tumor cells
  67. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells
  68. Zeolite/ZnO composites based on a Cuban natural clinoptilolite and preliminary evaluation in methylene blue adsorption
  69. Biguanide–transition metals complexes as potential drug for hyperglycemia treatment
  70. Chain-like uranyl-coordination polymer as a bright green light emitter for sensing and sunlight driven photocatalysis
  71. Chemical transformation of a luminescent two-dimensional Eu(iii) coordination polymer in the aqueous phase
  72. Crystal structure, anti-Trypanosoma cruzi and cytotoxic activities of Cu(II) complexes bearing β-diketone and α-diimine ligands
  73. New Allyldithiocarbimates: Synthesis, Structure and Antifungal Activity against Phakopsora pachyrhizi and Hemileia vastatrix
  74. Synthesis and solid-state characterization of diclofenac imidazolium monohydrate: an imidazolium pharmaceutical ionic liquid
  75. “Half-Sandwich”/RuII Anticancer Complexes Containing Triphenylphosphine and p-Substituted Benzoic Acids
  76. Silver(i) complexes of 3-methoxy-4-hydroxybenzaldehyde thiosemicarbazones and triphenylphosphine: structural, cytotoxicity, and apoptotic studies
  77. Rational design, supramolecular synthesis and solid state characterization of two bicomponent solid forms of mebendazole
  78. Green One-Pot Asymmetric Synthesis of Peptidomimetics via Sequential Organocatalyzed Aziridination and Passerini Multicomponent Reaction
  79. Data of synthesis, characterization and luminescence measurements in 1D lanthanide coordination polymers based on lanthanides
  80. Synthesis, spectroscopic (FT–IR and UV–Vis), crystallographic and theoretical studies, and a molecular docking simulation of an imatinib-like template
  81. Green Synthetic Methodology of (E)-2-cyano-3-aryl Selective Knoevenagel Adducts Under Microwave Irradiation
  82. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells
  83. THERMAL BEHAVIOR OF INOSINE 5’-MONOPHOSPHATE COMPLEXES WITH COBALT(II), NICKEL(II), COPPER(II) AND CADMIUM(II) CATIONS
  84. Crystal structures of two CuII compounds: catena-poly[[chloridocopper(II)]-μ-N-[ethoxy(pyridin-2-yl)methylidene]-N′-[oxido(pyridin-3-yl)methylidene]hydrazine-κ4 N,N′,O:
  85. 1D lanthanide coordination polymers based on lanthanides and 4′-hydroxi-4-biphenylcarboxylic acid: Synthesis, structures and luminescence properties
  86. Synthesis, structural characterization, and theoretical studies of new pyrazole (E)-2-{[(5-(tert-butyl)-1H-pyrazol-3-yl)imino]methyl}phenol and (E)-2-{[(1-(4-bromophenyl)-3-(tert-butyl)-1H-pyrazol-5-yl]imino]methyl}phenol
  87. Isolation, Identification, Predictions of Biological Activity and Molecular Docking of the Diterpene Jateorin Obtained from the Stem of Odontocarya tamoides (D.C.) Miers
  88. A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone
  89. Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
  90. Nickel complexes with phosphines and N-R-sulfonyldithiocarbimates ligands: New antifungals for the control of Hemileia vastatrix and Phakopsora pachyrhizi
  91. Fluconazole: Synthesis and Structural Characterization of Four New Pharmaceutical Cocrystal Forms
  92. Esterification of the free carboxylic group from the lutidinic acid ligand as a tool to improve the cytotoxicity of Ru(ii) complexes
  93. X-ray diffraction, vibrational and thermal study of dibenzazepinodione, a pharmacopeial impurity of oxcarbazepine
  94. Fluconazolium oxalate: synthesis and structural characterization of a highly soluble crystalline form
  95. When Serendipity Knocks on the Door: Synthesis and Physicochemical Characterization of 7-Chloro-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one
  96. Pharmaceutical paroxetine-based organic salts of carboxylic acids with optimized properties: the identification and characterization of potential novel API solid forms
  97. Supramolecular synthesis and characterization of crystalline solids obtained from the reaction of 5-fluorocytosine with nitro compounds
  98. Highly water soluble agrichemicals by using engineered organic salts for reducing adverse environmental impacts
  99. APLICAÇÃO DA ESPECTROSCOPIA RAMAN NA CARACTERIZAÇÃO DE MINERAIS PERTENCENTES A UMA GEOCOLEÇÃO
  100. In vitro Antiplasmodial Activities of Alkaloids Isolated from Roots of Worsleya procera (Lem.) Traub (Amaryllidaceae)
  101. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
  102. In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes
  103. Spergulagenic Acid A: Isolation and single crystal structure elucidation
  104. Modulating the water solubility and thermal stability of the anti-tuberculosis drug Isoniazid via multicomponent crystal formation
  105. Development of copper(II)-diimine-iminodiacetate mixed ligand complexes as potential antitumor agents
  106. The use of variable temperature 13 C solid-state MAS NMR and GIPAW DFT calculations to explore the dynamics of diethylcarbamazine citrate
  107. In vitro leishmanicidal activity and theoretical insights into biological action of ruthenium(II) organometallic complexes containing anti-inflammatories
  108. Rational Design of a Famotidine–Ibuprofen Coamorphous System: An Experimental and Theoretical Study
  109. Crystal Structure of N-(2-Cyano-1-Phenylprop-2-en-1-yl)-4-Methylbenzenesulfonamide
  110. Mechanochemical Synthesis of a Multicomponent Solid Form: The Case of 5-Fluorocytosine Isoniazid Codrug
  111. Synthesis, crystal structure, photophysical properties and theoretical studies of a novel bis(phenylisoxazolyl) benzene derivative
  112. Co-crystal structure of a dinuclear (Zn-Y) and a trinuclear (Zn-Y-Zn) complexes derived from a Schiff base ligand
  113. 5-Fluorocytosine/5-Fluorouracil Drug-Drug Cocrystal: a New Development Route Based on Mechanochemical Synthesis
  114. Protonation of inorganic 5-Fluorocytosine salts
  115. Synthesis, characterization and solubility of a new anthelmintic salt: Mebendazole nitrate
  116. Novel Solid Solution of the Antiretroviral Drugs Lamivudine and Emtricitabine
  117. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes
  118. Paroxetine and Fluoxetine Hexafluorosilicate salts: Synthesis, crystal structure, Hirshfeld surface, and supramolecular analysis
  119. {1-[1-(2-Hydroxyphenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}{1-[1-(2-oxidophenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}nickelate(...
  120. Antimicrobial activity of cis -[Ru(bpy) 2 (L)(L′)] n + complexes, where L = 4-(4-chlorobenzoyl)pyridine or 4-(benzoyl)pyridine and L′ = Cl − or CO
  121. Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism
  122. Novel Isoniazid cocrystals with aromatic carboxylic acids: Crystal engineering, spectroscopy and thermochemical investigations
  123. Ru(ii)–thyminate complexes: new metallodrug candidates against tumor cells
  124. A vanillin-based copper(ii) metal complex with a DNA-mediated apoptotic activity
  125. Avoiding irreversible 5-fluorocytosine hydration via supramolecular synthesis of pharmaceutical cocrystals
  126. Facile Synthesis and Characterization of Symmetric N-[(Phenylcarbonyl) carbamothioyl]benzamide Thiourea: Experimental and Theoretical Investigations
  127. Exploring physical and chemical properties in new multifunctional indium-, bismuth-, and zinc-based 1D and 2D coordination polymers
  128. Crystal engineering of multicomponent crystal forms of antituberculosis drugs
  129. Crystallochemical characterization of polyoxometalate new minerals
  130. Synthesis, characterization and reactivity of halides/pseudohalides and their complexes containing ruthenium II in the hydrogenation of cyclohexene
  131. Conformational and structural diversity of iridium dimethyl sulfoxide complexes
  132. Probing intermolecular interactions in a diethylcarbamazine citrate salt by fast MAS 1 H solid-state NMR spectroscopy and GIPAW calculations
  133. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells
  134. Spectroscopic (far or terahertz, mid-infrared and Raman) investigation, thermal analysis and biological activity of piplartine
  135. Synthesis, structural characterization and cytotoxic activity against tumor cells of heteroleptic copper (I) complexes with aromatic diimines and phosphines
  136. Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation
  137. Photochemical studies of cis -[Ru(bpy) 2 (4-bzpy)(CO)](PF 6 ) 2 and cis -[Ru(bpy) 2 (4-bzpy)(Cl)](PF 6 ): Blue light-induced nucleobase binding
  138. Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
  139. Development of a salt drug with improved solubility: Ethionamide nitrate
  140. Propyl gallate metal complexes: Circular dichroism, BSA-binding, antioxidant and cytotoxic activity
  141. Hydroxycalciomicrolite, Ca1.5Ta2O6(OH), a new member of the microlite group from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  142. Reducing the Hygroscopicity of the Anti-Tuberculosis Drug (S,S)-Ethambutol Using Multicomponent Crystal Forms
  143. Reactive nitrogen/oxygen species production by nitro/nitrosyl supramolecular ruthenium porphyrin complexes
  144. Copper(I)–Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity
  145. Syntheses, characterization and antifungal activity of novel dimethylbis(N-R-sulfonyldithiocarbimato)stannate(IV) complexes
  146. Order–disorder phase transition induced by proton transfer in a co-crystal of 2,4-dichlorobenzoic acid and trimethylamine N-oxide
  147. A Potential Visible-Light NO Releaser: Synthesis, Reactivity and Vasodilator Properties
  148. Polypyridyl Ruthenium Complexes: Novel DNA-Intercalating Agents against Human Breast Tumor
  149. Structural isomerism of Ru(ii)-carbonyl complexes: synthesis, characterization and their antitrypanosomal activities
  150. Studies on the Ru(II) monocationic complexes [RuCl 2 (NO)(P–N)(PR 3 )]PF 6 , where P–N = o -diphenylphosphino- N , N -dimethylaniline, and R = Ph and p -X-C 6 H 4 (X = OMe, Me, F)
  151. Ru(II)/bisphosphine/diimine/amino acid complexes: diastereoisomerism, cytotoxicity, and inhibition of tumor cell adhesion to collagen type I
  152. Correction to Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  153. Solution and Solid State Nuclear Magnetic Resonance Spectroscopic Characterization of Efavirenz
  154. X-Ray diffraction, spectroscopy and thermochemical characterization of the pharmaceutical paroxetine nitrate salt
  155. Diffractaic acid: Crystalline structure and physicochemical characterization
  156. On the Thermal Stability of the Diethylcarbamazine-Fortified Table Salt Used in the Control of Lymphatic Filariasis
  157. Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  158. Centrosymmetric resonance-assisted intermolecular hydrogen bonding chains in the enol form of β-diketone: Crystal structure and theoretical study
  159. Syntheses, characterization and antifungal activity of heteroleptic nickel(II) complexes with N-alkylsulfonyldithiocarbimates and phosphines
  160. Cationic Pd(II) complexes acting as topoisomerase II inhibitors: Synthesis, characterization, DNA interaction and cytotoxicity
  161. Reversible Solid-State Hydration/Dehydration of Paroxetine HBr Hemihydrate: Structural and Thermochemical Studies
  162. Looking for the interactions between omeprazole and amoxicillin in a disordered phase. An experimental and theoretical study
  163. Tetraphenylphosphonium allyldithiocarbimates derived from Morita-Baylis-Hillman adducts: Synthesis, characterization, crystal structure and antifungal activity
  164. Tuning the structure, dimensionality and luminescent properties of lanthanide metal–organic frameworks under ancillary ligand influence
  165. Supramolecular synthesis and thermochemical investigations of pharmaceutical inorganic isoniazid salts
  166. Rare earth coordination dinuclear compounds constructed from 3,5-dicarboxypyrazolate and succinate intermetallic bridges
  167. Influence of gold nanoparticles applied to catalytic hydrogenation of acetophenone with cationic complexes containing ruthenium
  168. Mechanochemistry applied to reformulation and scale-up production of Ethionamide: Salt selection and solubility enhancement
  169. Luminescence, chemical sensing and mechanical properties of crystalline materials based on lanthanide–sulfonate coordination polymers
  170. Chiral Platinum(II) Complexes Featuring Phosphine and Chloroquine Ligands as Cytotoxic and Monofunctional DNA-Binding Agents
  171. Crystal structure of 4-formyl-2-nitrophenyl 4-chloro-2-nitrobenzoate
  172. Crystal structure of 2-(4-chlorobenzamido)benzoic acid
  173. Cis-[RuCl(BzCN)(N–N)(P–P)]PF6 complexes: Synthesis and in vitro antitumor activity
  174. Vibrational and thermal analyses of multicomponent crystal forms of the anti-HIV drugs lamivudine and zalcitabine
  175. Exploring the System Lanthanide/Succinate in the Formation of Porous Metal–Organic Frameworks: Experimental and Theoretical Study
  176. Crystal structure and catalytic activity of ruthenium (II)/dithiocarbamate complexes in the epoxidation of cyclooctene
  177. Copper(II) complexes with β-diketones and N-donor heterocyclic ligands: Crystal structure, spectral properties, and cytotoxic activity
  178. Isostructurality and the conformational role of the 2′,3′-moieties in the diversity of lamivudine crystal forms probed in halide salts
  179. Anti-Mycobacterium tuberculosisand Cytotoxicity Activities of Ruthenium(II)/Bipyridine/Diphosphine/Pyrimidine-2-thiolate Complexes: The Role of the Non-CoordinatedN-Atom
  180. Ruthenium(II) complexes with hydroxypyridinecarboxylates: Screening potential metallodrugs against Mycobacterium tuberculosis
  181. Crystal Growth & Design Celebrates the International Year of Crystallography 2014
  182. DFT investigation on hydrogen bonding in cyclohexane-1,2,3,4,5-pentol crystal structure
  183. Crystal structure of 4-bromo-N-(2-hydroxyphenyl)benzamide
  184. Crystal structure of 2-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide
  185. Crystal structure of (±)-3-[(benzo[d][1,3]dioxol-5-yl)methyl]-2-(3,4,5-trimethoxyphenyl)-1,3-thiazolidin-4-one
  186. Temperature-Driven Isosymmetric Reversible Phase Transition of the Hormone Estradiol 17β Valerate
  187. Solid-State Supramolecular Synthesis Based on the N–H…O Heterosynthon: An Approach to Solve the Polymorphism Problem in Famotidine
  188. Saddle-shaped macrocycle distortion and symmetry decrease in cobalt (II) meso-tetraphenylporphyrin: Structure of a dichloromethane solvate and DFT calculations
  189. Effect of the Methanol Molecule on the Stabilization of C 18 H 18 O 4 Crystal: Combined Theoretical and Structural Investigation
  190. Structural features and cytotoxic activities of [Ru(AA-H)(dppb)(bipy)]PF6 complexes
  191. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)–dipeptide–phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer
  192. Controlled Synthesis of New 5-Fluorocytosine Cocrystals Based on the p K a Rule
  193. Nitro/Nitrosyl-Ruthenium Complexes Are Potent and Selective Anti-Trypanosoma cruzi Agents Causing Autophagy and Necrotic Parasite Death
  194. Modified glassy carbon electrode with AuNPs using cis-[RuCl(dppb)(bipy)(4-vpy)]+ as crossed linking agent
  195. Antiparasitic activities of novel ruthenium/lapachol complexes
  196. fac-[1,2-Bis(pyridin-4-yl)ethane-κN]tricarbonyl(1,10-phenanthroline-κ2N,N′)rhenium(I) hexafluoridophosphate acetonitrile monosolvate
  197. [4-(Allyloxy)phenyl](phenyl)methanone
  198. 2,4,6-Trinitrophenyl 3-bromobenzoate
  199. 2-[(1-Oxidopyridin-4-yl)sulfanyl]benzoic acid
  200. 3-(Diphenylamino)isobenzofuran-1(3H)-one
  201. Synthesis, characterization and phytotoxic activity of hydroxylated isobenzofuran-1(3H)-ones
  202. Halogen⋯halogen contacts for the stabilization of a new polymorph of 9,10-dichloroanthracene
  203. 2,2′-(1,4-Phenylene)bis(propane-2,2-diyl) bis(benzodithioate)
  204. Quasi-enantiomeric single-nucleoside and quasi-racemic two-nucleoside hydrochloride salts and ruthenium complexes of cytidine and 2′,3′-dideoxycytidine analogs unveiling the negligible structure-driving role of the 2′,3′-moieties
  205. Unusual hydrogen bond patterns contributing to supramolecular assembly: conformational study, Hirshfeld surface analysis and density functional calculations of a new steroid derivative
  206. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole
  207. Ruthenium(II)/4,6-dimethyl-2-mercaptopyrimidine complexes: Synthesis, characterization, X-ray structures and in vitro cytotoxicity activities on cancer cell lines
  208. Structural and vibrational study of 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone – A potential metal–protein attenuating compound (MPAC) for the treatment of Alzheimer’s disease
  209. 4-Formyl-2-nitrophenyl 2-chlorobenzoate
  210. The Continuum in 5-Fluorocytosine. Toward Salt Formation
  211. Mebendazole Mesylate Monohydrate: A New Route to Improve the Solubility of Mebendazole Polymorphs
  212. Fluorcalciomicrolite, (Ca, Na, 〈)2Ta2O6F, a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  213. The effect of guest molecules on the conformation and molecular assembly of the fac-[RuCl3(NO)(dppb)] complex
  214. NH⋯Br, Br⋯π and π⋯π interactions toward self-assembly of the cytosine hydrobromide: Crystal structure, infrared spectroscopy and thermal behavior
  215. 2-[1′-(Benzyloxy)spiro[indane-1,2′-pyrrolidine]-5′-yl]acetonitrile
  216. (±)-3-(5-Amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-benzofuran-1(3H)-one
  217. Industrial Scale Isolation, Structural and Spectroscopic Characterization of Epiisopiloturine from Pilocarpus microphyllus Stapf Leaves: A Promising Alkaloid against Schistosomiasis
  218. 2,4,6-Trinitrophenyl 3-chlorobenzoate
  219. Supramolecular study, Hirshfeld analysis and theoretical study of 6-methoxyquinolineN-oxide dihydrate
  220. 4-Formyl-2-nitrophenyl 4-bromobenzoate
  221. X-ray Crystal Structures of Intermediates of the Stereoselective (±)-Grandisol Synthesis Based on the Remote Alkylation Protocol
  222. 2,2′-(Carbonothioyldisulfanediyl)bis(2-methylpropanoic acid)
  223. Synthesis, crystal structure and photoluminescence of a binuclear complex of europium(III) containing 3,5-dicarboxypyrazolate and succinate
  224. 2,4,6-Trinitrophenyl 4-chlorobenzoate
  225. 5-Chloroquinolin-8-yl furan-2-carboxylate
  226. Study of a series of cobalt(II) sulfonamide complexes: Synthesis, spectroscopic characterization, and microbiological evaluation against M. tuberculosis. Crystal structure of [Co(sulfamethoxazole)2(H2O)2]·H2O
  227. New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents
  228. A new copper(II) complex with 2-thenoyltrifluoroacetone and 2,2-bipyridine: Crystal structure, spectral properties and cytotoxic activity
  229. Electrochemical and Monte Carlo studies of self-assembled trans-[Fe(cyclam)(NCS)2]+ complex ion on gold surface as electrochemical sensor for nitric oxide
  230. Hydrokenomicrolite, ( ,H2O)2Ta 2(O,OH)6(H2O), a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  231. cis-Bis(1,10-phenanthroline-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate)
  232. cis-Bis(2,2′-bipyridine-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate) acetonitrile monosolvate
  233. Understanding the Solid Forms of 5E-phenylethenylbenzofuroxan with Differentin vivoanti-T. cruziActivity
  234. 16α-Hydroxyfriedelin and 3-Oxo-16-methylfriedel-16-ene as Building Blocks: Crystal Structure and Hirshfeld Surfaces Decoding Intermolecular Contacts
  235. Novel sesquiterpene lactones from Eremanthus seidelii
  236. Crystal Structure of Limonoid 6-O-Acetylswietephragmin E and Theoretical Study of Nuclear Magnetic Resonance Spectra of Phragmalin Limonoids
  237. 3,5-Bis(benzyloxy)benzoic acid
  238. 2,4,6-Trinitrophenyl 4-methylbenzoate
  239. Base-Paired and Base-Stacked Structures of the Anti-HIV Drug Lamivudine: A Nucleoside DNA-Mimicry with Unprecedented Topology
  240. Synthesis, crystal structure and magnetic properties of the helical oxalate-bridged copper(II) chain {[(CH3)4N]2[Cu(C2O4)2] · H2O}n
  241. Ethyl 2-(3-phenylthioureido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
  242. Synthesis and characterization of [Ru(η6-C10H14)(dppf)X][PF6] (X=Cl, Br, I, SnF3) compounds: The X-ray structure of [Ru(η6-C10H14)(dppf)Cl][SnCl3]·0.45CH2Cl2
  243. 2,4,6-Trinitrophenyl 3-methylbenzoate
  244. 6-Bromopyridine-2-carbaldehyde phenylhydrazone
  245. Lamivudine Salts with Improved Solubilities
  246. 9-(4-Bromobutyl)-9H-carbazole
  247. Synthesis and characterization of the atropisomeric relationships of a substituted N-phenyl-bipyrazole derivative with anti-inflammatory properties
  248. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor
  249. Cyclopropane- and spirolimonoids and related compounds from Hortia oreadica
  250. Host–guest interactions between xanthones and water: the role of O–H···O, C–H···O, and π···π contacts in the channel- and cage-type frameworks
  251. Pseudopolymorphism in hydroxybenzophenones: the dihydrate of 2,2′,4,4′-tetrahydroxybenzophenone
  252. Influence of hydrogen bonds on the molecular structure and conformations of two (C30H48O2) pentacyclic triterpene isomers
  253. Salts of the anti-HIV drug lamivudine with phthalic and salicylic acids
  254. Toward supramolecular architectures of the anti-HIV drug lamivudine: understanding the effect of the inclusion of water in a hydrochloride form
  255. Form III-like conformation and Form I-like packing in a chloroform channel solvate of the diuretic drug chlortalidone
  256. X-ray diffraction and theoretical investigation of the Gedunin crystal structure
  257. Preparation, characterization and structure of ruthenium phosphine complexes containing non-innocent ligands
  258. Hydrothermal syntheses of ETS-10 like vanadosilicates using chiral organic molecules. Part I
  259. 4-Methylphenyl 4-bromobenzoate
  260. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis
  261. Syntheses, crystal structure and theoretical investigation of novel heteroleptic complexes of nickel(II) with N-R-sulfonyldithiocarbimate and phosphine ligands
  262. Rankamaite from the Urubu pegmatite, Itinga, Minas Gerais, Brazil: Crystal chemistry and Rietveld refinement
  263. Weak C—H...Cl—Pd interactions toward conformational polymorphism intrans-dichloridobis(triphenylphosphane)palladium(II)
  264. A monoclinic polymorph of the ticlopidine hydrochloride
  265. Crystal structure of the drug diethylcarbamazine and a new maleate salt
  266. Supramolecular chemistry of anti-HIV nucleoside drugs: toward smart crystal phases and self-assembled DNA-mimicries
  267. Asymmetric heterobimetallic mixed-valence complex trans-[(SO3)Co(cyclam)(NCS)Ru(NH3)4(NCS)](BF4): Synthesis and characterization
  268. Experimental and theoretical investigation of molecular structure and conformation of the 4-isopropylthioxanthone
  269. fac-/mer-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine): Synthesis, characterization and DFT calculations
  270. Conformational polymorphism of the antidiabetic drug chlorpropamide
  271. cis-Bis[1,1-dibenzyl-3-(furan-2-ylcarbonyl)thioureato-κ2O,S]copper(II)
  272. THE CRYSTAL STRUCTURE OF A MICROLITE-GROUP MINERAL WITH A FORMULA NEAR NaCaTa2O6F FROM THE MORRO REDONDO MINE, CORONEL MURTA, MINAS GERAIS, BRAZIL
  273. Study of the phenanthroline-Mn-imidazole bonding in Mn(I) triscarbonyl complex: A X-ray and DFT computational analysis
  274. cis-Bis{1,1-dibenzyl-3-[(furan-2-yl)carbonyl]thioureato-κ2O,S}nickel(II)
  275. Tetrachlorocarbonyliridates: Water-Soluble Carbon Monoxide Releasing Molecules Rate-Modulated by the Sixth Ligand
  276. Synthesis and Crystal Structures of Octahedral Sn(IV) Complexes Prepared from SnCl2·2H2O and 2-Hydroxyacetophenone (S-benzydithiocarbazate) Ligand (H2L)
  277. 4-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid: X-ray and DFT-calculated structure
  278. Design of 1D and 2D molecule-based magnets with the ligand 4,5-dimethyl-1,2-phenylenebis(oxamato)
  279. Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride
  280. The mer-[RuCl3(dppb)(H2O)] complex: A versatile tool for synthesis of RuII compounds
  281. 2-(Phenylcarbonothioylsulfanyl)acetic acid
  282. 3-Nitrophenol–4,4′-bipyridylN,N′-dioxide (2/1): a DFT study and CSD analysis of DPNO molecular complexes
  283. Triple Structural Transition below Room Temperature in the Antifilarial Drug Diethylcarbamazine Citrate
  284. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement
  285. On the synthesis and structures of the complexes [RuCl(L)(dppb)(N–N)]PF6 (L=CO, py or 4-NH2py; dppb=1,4-bis(diphenylphosphino)butane; N–N=2,2′-bipyridine or 1,10-phenanthroline) and [(dppb)(CO)Cl2-Ru-pz-RuCl2(CO)(dppb)] (pz=pyrazine)
  286. Oxorhenium(V) Complexes with 2,3-Dihydroxynaphthalene
  287. 2-[(2-Carboxyphenyl)disulfanyl]benzoic acid–4,4′-bipyridylN,N′-dioxide (1/2)
  288. ChemInform Abstract: 6-Deoxyjacareubin.
  289. ChemInform Abstract: Serendipitous, One-Pot Formation of 2,3,7-Triphenylcyclopenta[c]pyran from 1,2-Diphenylethanedione (“Benzil”) and Cyclopentadiene.
  290. Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes
  291. Solvothermal Preparation of Drug Crystals: Didanosine
  292. From Rational Design of Drug Crystals to Understanding of Nucleic Acid Structures: Lamivudine Duplex
  293. Structural and magnetic properties of the oxyborateCo5Ti
  294. On the relationships between molecular conformations and intermolecular contacts toward crystal self-assembly of mono-, di-, tri-, and tetra-oxygenated xanthone derivatives
  295. Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity
  296. Dependence of the product on the P–P ligand in reactions of [RuCl3(NO)(P–P)] complexes (P–P=aromatic diphosphines) with 2-mercaptopyridine
  297. Experimental and theoretical study of the kinetics of dissociation in cis-[RuCl2(P-P)(N-N)] type complexes
  298. Efficient synthesis of benzothiazine and acrylamide compounds
  299. A novel and simple synthetic route for a piperazine derivative
  300. Palladium(II) complexes with thiosemicarbazones: syntheses, characterization and cytotoxicity against breast cancer cells and Anti-Mycobacterium tuberculosis activity
  301. Crystal Engineering of an Anti-HIV Drug Based on the Recognition of Assembling Molecular Frameworks
  302. Structural relationships in the solid state of the anti-chagas agent (E)-phenylethenylbenzofuroxan
  303. Driving forces in substitution reactions of octahedral complexes: The influence of the competitive effect
  304. Synthesis, structural characterization and ex vivo biological properties of a new complex [Cu(propranolol)2]·2H2O, a potential beta-blocker
  305. Imidazolium fumarate
  306. Heterobimetallic compounds [Ru(η5-Cp)(dppf)X] (X = Cl, Br, I and N3): synthesis, electrochemical analysis, and the crystal structure of [Ru(η5-Cp)(dppf)I] [dppf = 1,1′-bis(diphenylphosphino)ferrocene]
  307. Bis(tetraphenylphosphonium) tris[N-(methylsulfonyl)dithiocarbimato(2−)-κ2S,S′]stannate(IV)
  308. Synthesis, characterization, and single crystal X-ray structure of the 1-furoyl-3-cyclohexylthiourea cadmium chloride complex, Cd[C4H3OC(O)NHC(S)NHC6H11]4Cl2
  309. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C
  310. Conformational Polymorphism in Racemic Crystals of the Diuretic Drug Chlortalidone
  311. 3-Nitrobenzoic acid–3-methyl-4-nitropyridine 1-oxide (1/1)
  312. On an Electrode Modified by a Supramolecular Ruthenium Mixed Valence (Ru II /Ru III ) Diphosphine-Porphyrin Assembly
  313. Molecular conformation of the racemic indan derivative (±)-1-trans-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-indene-1-carboxamide
  314. 4-{2-[4-(Dimethylamino)phenyl]ethylidene}benzonitrile
  315. Partial magnetic ordering and crystal structure of the ludwigitesCo2
  316. 1-Furoyl-3-[3-(trifluoromethyl)phenyl]thiourea
  317. Diphenyllead(IV) thiosemicarbazonates and pyrazolonates: Synthesis and characterization
  318. Redetermination of 1-benzyl-3-furoyl-1-phenylthiourea
  319. Preparation of Achiral and Chiral (E)-Enaminopyran-2,4-diones and Their Phytotoxic Activity
  320. Spectroscopic Investigation on the Formation of a Dinuclear Me2SO–Ru2-Mercaptopyridine Bridged Complex: [Ru2Cl3(μ-pyS)(μ-dmso)(dmso)4] · 2H2O
  321. Lupeol
  322. Vanadium complexes with thiosemicarbazones: Synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity
  323. Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: Orally effective anti-inflammatory drug candidates
  324. Synthesis, structural characterization and conformational aspects of nostoclide analogues
  325. Organotin Complexes of Alizarin and Purpurin
  326. Different coordination modes for disulfoxides towards diorganotin(IV) dichlorides. X-ray crystal structures of 1,2-cis-bis-(phenylsulfinyl)ethene (rac-,cis-cbpse) and adducts [{Ph2SnCl2(meso-bpse)}n] and [{n-Bu2SnCl2(pdtd)}2]
  327. Study of the [Zn(H2O)4CuEDTA]·2H2O Complex, a Potential Trace-metal Supplier: Synthesis, Crystal Structure, Spectroscopic Behavior and Metal Release
  328. Analyzing Ru(III)–dmso and Ru(III)–dms motifs in compounds used in the synthesis of the antimetastatic agents
  329. N-(4-Chlorophenyl)maleimide
  330. Rhenium chelate complexes with maltolate or kojate
  331. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the “SpymMe2” ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine
  332. Powder X-ray diffraction study of polymorphic drugs: fluconazole and mebendazole
  333. 1-(o-Tolyl)thiourea
  334. N-(2-Furylcarbonyl)piperidine-1-carbothioamide
  335. 1-(2-Furoyl)-3-(o-tolyl)thiourea
  336. Crystal Structure of Garciniaphenone and Evidences on the Relationship between Keto-Enol Tautomerism and Configuration
  337. Hydrogen bonding in 2-(2-oxothiazolidin-3-yl)-4,5-dihydrothiazolium hydrogen sulfate monohydrate
  338. 1-(3-Cyanophenyl)-3-(2-furoyl)thiourea
  339. Quantum-chemical, NMR and X-ray diffraction studies on (±)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane
  340. 1-Furfuryl-3-furoylthiourea
  341. Structure and magnetism of homometallic ludwigites:Co3O
  342. Synthesis and Characterization of a New Copper(II) Complex with Nadolol, an Aminoalcoholic Beta-blocker. Crystal Structure of Na[Cu(nadololate)(CO3)] · H2O
  343. N-(3-Chlorophenyl)maleimide
  344. 8-Hydroxy-5,6,7-trimethoxy-2-phenyl-4H-chromen-4-one
  345. Lead(II)-induced formation and coordination of 3,4-dihydro-3-thioxo-1,2,4-triazin-5(2H)-one
  346. Dimethylthallium(III) complexes with picolinic acid and its hydroxyl derivatives
  347. Ruthenium(II) complexes containing N(4)-tolyl-2-acetylpyridine thiosemicarbazones and phosphine ligands: NMR and electrochemical studies of cis–trans isomerization
  348. Crystal Structures and Thermal Behavior of Alkaline Earth Tricyanomethanides
  349. New Ni(II)-sulfonamide complexes: Synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4]·2H2O and [Ni(sulfapyridine)2]
  350. Menezesite, the first natural heteropolyniobate, from Cajati, Sao Paulo, Brazil: Description and crystal structure
  351. Synthesis and Characterization of a New Mebendazole Salt: Mebendazole Hydrochloride
  352. New insights on the Lewis acidity of diorganolead(IV) compounds: Diphenyllead(IV) complexes with N,O,S-chelating ligands
  353. Synthesis of novel O-acylated-D-ribono-1,5-lactones and structural assignment supported by conventional NOESY-NMR and x-ray analysis
  354. Sobre uma degenerescência acidental nos deslocamentos químicos de RMN de 31P{¹H} em complexos difosfínicos de rutênio
  355. Crystalline Structure of Mangiferin, aC-Glycosyl-Substituted 9H-Xanthen-9-one Isolated from the Stem Bark ofMangifera indica
  356. New Pd(II) and Pt(II) complexes with N,S-chelated pyrazolonate ligands: Molecular and supramolecular structure and preliminary study of their in vitro antitumoral activity
  357. Novel manganese (III) porphyrin containing peripheral “[RuCl(dppb)(X-bipy)]+” cations [dppb=1,4-bis(diphenylphosphino)butane and X=–CH3, –OMe, –Cl]. X-ray structure of the cis-[RuCl(dppb)(bipy)(4-Mepy)]PF6 complex
  358. Low-temperature study of a new nevirapine pseudopolymorph
  359. 2-Benzoylpyridine semicarbazone
  360. Synthesis, characterization and crystal structure of a novel thiocyanate–ruthenium(II) complex
  361. Heterobimetallic [Ru(II)/Fe(II)] complexes: On the formation of trans- and cis-[RuCl2(dppf)(diimines)]
  362. Synthesis, characterization, X-ray structure and preliminary in vitro antitumor activity of the nitrosyl complex fac-[RuCl3(NO)(dppf)], dppf=1,1′-bis(diphenylphosphine)ferrocene
  363. Crystal structure, electrochemical and photochemical studies of the trans-[Fe(cyclam)(NO)Cl]Cl2 complex (cyclam=1,4,8,11-tetraazacyclotetradecane)
  364. New lead(II) complexes with N,S-ligands, including a lead pyrazolonate with unusual packing flexibility
  365. Crystal structure and anticonvulsant activity of (±)-1,2:4,5-di-O-isopropylidene-3,6-di-O-(2-propylpentanoyl)-myo-inositol
  366. X-ray structure and EPR behavior of a new dimeric copper(II) complex with 4-amino-N-(5-methoxy-2-pyrimidinyl)benzenesulfonamide
  367. Methyllead(IV) Derivatives Stabilized by DAPTSC2–: Synthesis and Structures of New Diorganolead(IV) Complexes
  368. Novel Gold(I) 7-Azacoumarin Complex:  Synthesis, Structure, Optical Properties, and Cytotoxic Effects
  369. Synthesis and structural characterization of two nostoclide analogues
  370. Correlation between quadrupole splitting (Δ) and the θ angle (C–Sn–C) in five-coordinate diphenyltin(IV) complexes. X-ray crystal structures of [Ph2Sn(hacm)] and [Ph2Sn(hacmm)] containing O,N,S-tridentate N 4-heterocyclic thiosemicarbazones
  371. 2,2′,4-Trihydroxybenzophenone: Crystal Structure, and Anti-Inflammatory and Antioxidant Activities
  372. Physicochemical characterization of deflazacort: Thermal analysis, crystallographic and spectroscopic study
  373. The preparation of new oxoniobium(V) complexes from hydrated Niobium(V) Oxide: the crystal and molecular structure of Oxotris(2-pyridinolato-N-oxide)niobium(V)
  374. Pseudohalides of Main Group Metals: The Alcaline Earth Tricyanomethanides - The Crystal Structures of Calcium and Barium Tricyanomethanide.
  375. Natural polyprenylated benzophenones: keto-enol tautomerism and stereochemistry
  376. The first P–N containing RuCl3NO complex: fac-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine)
  377. Novel zwitterionic oxorhenium(V) complexes: synthesis, characterization and crystal structure of [ReOX2(Hdhp)(PPh3)] (X = Cl, Br; H2dhp = 2,3-dihydroxypyridine)
  378. Matioliite, the Mg-analog of burangaite, from Gentil mine, Mendes Pimentel, Minas Gerais, Brazil, and other occurrences
  379. A gold(I) complex with a vitamin K3 derivative: Characterization and antitumoral activity
  380. 7-Amino-1-(3-bromophenyl)-3-cyanopyrazolo[4,3-d]pyrimidine
  381. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests
  382. Structural characterization of a series of new Cu-dipeptide complexes in solid state and in solution
  383. Magnetic properties of copper(II) complexes containing peptides. Crystal structure of [Cu(phe-leu)]
  384. Synthesis, 119Sn Mössbauer spectroscopic studies and X-ray crystal structure determination of new seven-coordinate diorganotin(IV) complexes with S,N,N,N,S-pentadentate Schiff bases derived from 2,6-diacetylpyridine of S-methyl- and S-benzyldithiocarba...
  385. On a ruthenium nitrosyl and monocoordinated biphosphine monoxide complex: Synthesis, characterization and X-ray structure of
  386. Preparation, crystal structure and spectroscopic characterization of nickel(II) complexes with dithiocarbimate derivated of sulfonamides
  387. Copper complexes with heterocyclic sulfonamides: Synthesis, spectroscopic characterization, microbiological and SOD-like activities: Crystal structure of [Cu(sulfisoxazole)2(H2O)4]·2H2O
  388. Structure and Vasorelaxant Activity of Floranol, a Flavonoid Isolated from the Roots ofDioclea grandiflora
  389. Influence of ligands on the isomerization in [RuCl3(NO)(P–P)] complexes, [P–P=R2P(CH2)nPR2 (n=1–3) and R2P(CH2)POR2, PR2–CHCH–PR2, R=Ph and (C6H11)2P-(CH2)2-P(C6H11)2]
  390. Mammeigin
  391. Polymorphism on Leflunomide: Stability and Crystal Structures
  392. The versatility of the 1,4-dithiane ligand towards the coordination chemistry of ruthenium-phosphine complexes
  393. The role of solvent in coordination polymers: The structures of catena-[Hg(μ2-O2PPh2)2] and catena-[Hg(μ2-O2PPh2)2(NC5H5)2]
  394. Experimental and theoretical structure characterization of two isoniazid derivatives: 2,4-Difluoro-N′-isonicotinoylbenzohydrazide and 2,4-dichloro-N′-isonicotinoylbenzohydrazide hydrochloride
  395. Ruthenium Phosphine/Diimine Complexes: Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones.
  396. Bis(diphenylphosphinato-κO)bis(diphenylphosphinic acid-κO)bis(pyridine-κN)mercury(II)
  397. Mono- and dinuclear copper(I) complexes with methyl-substituted pyrimidinethiones
  398. A pentacyclic triterpene from Maytenus imbricata: structure elucidation by X-ray crystallography
  399. Synthesis, characterisation and molecular structure of stannyl derivatives of molybdenum and iron
  400. Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine
  401. Synthesis, characterization and structure of ruthenium(II) phosphine complexes with N-heterocyclic thiolate ligands
  402. A Crystalline Phase Transition and Optical Properties in a CoIICuII Oxamato-Bridged Ferrimagnetic Chain
  403. Ruthenium Phosphine/Diimine Complexes:  Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones†
  404. The RuCl3(dppb)H2O complex: A new metal-assisted oxidative dehydrogenation of the o-phenylenediamine ligand
  405. Leaf-cutting ants toxicity of limonexic acid and degraded limonoids from Raulinoa echinata.: X-ray structure of epoxy-fraxinellone
  406. Limonoids from Spiranthera odoratissima St. Hil
  407. Synthesis and characterization of nitrosyl complexes containing 4,6-dimethyl-pyrimidine-2-thiolato (‘SpymMe2’) as ligand: [Ru(‘SpymMe2’,-N,-S) (‘SpymMe2’,-S)(NO)(P–P)](PF6) (P–P=1,2-bis(diphenylphosphino)ethane or 1,2-bis(diphenylphosphino)ethylene
  408. Magnetic and structural properties of two open-frameworks Nd(III) adipates
  409. Structural insights of a potential inhibition against leishmania major
  410. Factors determining polymorphism of leflunomide
  411. Magnetic and structural properties of rare earth hybrid frameworks
  412. Experimental electron density of [Cu(phen)2Cl](NO3)(H2O)
  413. An Alternative Method for the Preparation of Diphenylboron Chelates. The Crystal and Molecular Structures of (Pyridine-2-acetyloximato)diphenylboron and (1-Phenylazo-2-naphtholato)diphenylboron
  414. Molecular and Supramolecular Structures of 1-Phenyl-4-phenylacetyl-2-thiosemicarbazide (H2L) and its Complexes with Diphenyllead(IV) Chloride and Acetate
  415. Electron density distribution in the pyroborateMn2B...
  416. 5-Nitro-2-furaldehydeN-(hydroxymethyl)semicarbazone
  417. Ruthenium complexes containing the hemilabile ligand PPh2(CH2)P(O)PPh2 (dppmO): reactivity towards CO and X-ray molecular structures of tcc-RuCl2(η2-dppmO)2 and mer-RuCl3(η1,η2-dppmO)2
  418. New pyrone and quinoline alkaloid from Almeidea rubra and their trypanocidal activity
  419. The synthesis and characterisation of Sn(IV) complexes of 2,6-pyridine dicarboxylate — the molecular structure of divinyltin(IV) derivative
  420. Layered poly[μ2-aqua-μ3-dimethylformamide-di-μ3-phenylphosphonato-dipotassium]
  421. Synthesis, characterization, and structure of a new N-nitrosamine of cyclam (1,4,8,11-tetraazacyclotetradecane)
  422. 31P{1H}-n.m.r. as a tool for identification of ruthenium isomers containing PPh3 or 1,4-bis(diphenylphosphino)butane ligands. X-ray structures of the cis-{RuCl2(PPh3)2 [4,4′-(-X)2-2,2′-bipy]} complexes [X=-H, -Me, -SMe and (-Cl, -Me)]
  423. Candesartan cilexetil, an antihypertensive agent containing an extended double ester chain
  424. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].Imine hydrogenation using mono- and binuclear ruth...
  425. Polymeric chains, hydrogen bonds and magnetism in Nd(III) adipates
  426. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes
  427. Neo-clerodane diterpenoid, a new metalloprotease snake venom inhibitor from Baccharis trimera (Asteraceae): anti-proteolytic and anti-hemorrhagic properties
  428. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].
  429. Syntheses, characterization and X-ray structure of potassium hydrotris(2-mercaptothiazolyl)borate, KMt, and potassium hydrotris(methimazole)borate, KTm
  430. N2,S-versus N3,S-coordination in thiosemicarbazonate complexes: only a steric influence?
  431. Crystal structure and spectral characterization of dimethylthallium (III) complexes with 2-mercaptonicotinic acid and esters
  432. The effect of the cation substitution on the structural and vibrational properties of Cs2NaGaxSc1−xF6 solid solution
  433. Crystal structure and vibrational spectrum of the NaCaMg2F7 pyrochlore
  434. The synthesis and structural characterisation of [Ru(η-Cp)(dppf)SnBr3]
  435. Synthesis, characterisation and thermal decomposition of tin(IV) dithiocarbamate derivatives – single source precursors for tin sulfide powders
  436. Synthesis, Structural, Spectroscopic and Electrochemical Characterization of New Ruthenium(II) Tetramer Complexes Containing 1,4-Bis(diphenylphosphine)butane and Alterdentate Ligands
  437. Reaction of R(Ph)SnCl2(R=Me, Et) with 2,6-diacetylpyridine bis(thiosemicarbazone) (H2DAPTSC): the crystal structures of [Me(Ph)Sn(HDAPTSC)]Cl·1.25 MeOH and [Et(Ph)Sn(H2DAPTSC)]Cl2·MeOH·H2O
  438. Crystallographic report: Supramolecular structure of 2-aminonicotinatodimethylthallium(III),[TlMe2(2anic)]n
  439. Preparation, crystal structure and spectroscopic characterization of novel N-R-sulfonyldithiocarbimate platinum(II) complexes
  440. The Reaction of Dimethyltin(IV) Dichloride with Thiamine Diphosphate (H2TDP):  Synthesis and Structure of [SnMe2(HTDP)(H2O)]Cl·H2O, and Possibility of a Hitherto Unsuspected Role of the Metal Cofactor in the Mechanism of Vitamin-B1-Dependent Enzymes
  441. Structural, spectroscopic and redox studies of a new ruthenium(III) complex with an imidazole-rich tripodal ligand
  442. The Zn2+salt of pamidronate: a role for water in the metal–cation binding properties of bisphosphonates
  443. Crystallographic report: Ethyltriphenyltin(IV), Et(Ph)3Sn
  444. Potassium tetrakis(2-mercaptothiazolyl)borate; an open-framework material: synthesis and X-ray structure analysis
  445. A new monoclinic polymorph of methylp-aminobenzoate
  446. New thallium(III) chloride complexes with pyridine carboxylic acids: from molecular compounds to supramolecular associations
  447. Synthesis, crystal structures and spectroscopic properties of dichloroethylphenyltin(IV) and its phenanthroline adduct
  448. Dichloro(diphosphine)(2-pyridyl-ketone)ruthenium(II) complexes
  449. New Crystals in the Lithium Sulfate Family.
  450. 3-(5,7-Dimethoxy-2,2-dimethyl-2H-benzo[b]pyran-6-yl)propionic acid: a potential inhibitor against Leishmania
  451. Redetermination of skimmianine: a new inhibitor against the Leishmania APRT enzyme
  452. Redetermination and comparative structural study of isopimpinellin: a new inhibitor against the Leishmania APRT enzyme
  453. New crystals in the lithium sulfate family
  454. Design, Synthesis, and Evaluation of Analogues of 3,3,3-Trifluoro-2-Hydroxy-2-Phenyl-Propionamide as Orally Available General Anesthetics
  455. 3-(Benzoxazol-2-yl)-7-hydroxychromen-2-one methanol solvate
  456. Two members of the bisphosphonate class of drugs: a zwitterion and a molecular compound
  457. 2-Cyano-N-(2-hydroxyphenyl)acetamide
  458. Compositional and Structural Variety of Diphenyllead(IV) Complexes Obtained by Reaction of Diphenyllead Dichloride with Thiosemicarbazones
  459. Structure and magnetism ofMnMgB2
  460. 17α,21-Dihydroxy-16β-methylpregna-1,4-diene-3,11,20-trione (meprednisone)
  461. 4-(2-Isonicotinoylhydrazino)-4-oxobutanoic acid
  462. Synthesis and characterization of new ruthenium complexes with active ligands against Chagas' disease
  463. Redetermination of nickel bis(dithiocarbamate) at 100 K
  464. Synthesis, Spectroscopic and Structural Aspects of Mono‐ and Diorganothallium(III) Complexes of 2, 6‐Diacetylpyridine Bis(thiosemicarbazone) (H2DAPTSC) — A New Coordination Mode of the HDAPTSC— Anion
  465. 3-Oxoolean-12-en-20-yl α-methylcarboxylate
  466. A novel diterpene lactone
  467. fac-[RuCl3(NO)(dppb)] (I) and mer-[RuCl3(NO)(diop)] (II) complexes: syntheses, characterization and X-ray structures
  468. Novel Organophosphorus Cage Compound Produced by an Unexpected Oxidative Coupling of 1,2,4-Triphosphole: Crystal and Molecular Structures of Two Isomers of Formula P6C4Bu t4 CHSiMe3
  469. Syntheses, characterization and X-ray structures of the fac-[RuCl3(NO)(dppe)] and the trans-[RuCl(NO)(dppe)2]2+ species
  470. Charge density study of hexaaquazinc(II) dihydrogen-1,2,4,5-benzenetetracarboxylate
  471. Supramolecular organization in ruthenium complexes
  472. Supramolecular arrangement in dimethyl thallium complexes through Tl...S
  473. Crystal structure of cobalt-based chain molecular magnet CoCu(opba)(DMSO)3at room temperature and 100 K
  474. New Cages Derived from 1,2,4-Triphosphol
  475. Losartan potassium, a non-peptide agent for the treatment of arterial hypertension
  476. On the lability of dimethylsulfoxide (DMSO) coordinated to the {RuII–NO+} species: X-ray structures of mer-[RuCl3(DMSO)2(NO)] and mer-[RuCl3(CD3CN)(DMSO)(NO)]
  477. Single-crystal structure determination and infrared reflectivity study of the Li2CaHfF8 scheelite
  478. Crystal structure, electrochemical and spectroscopic properties of the trans-K{[FeCl(NO0)(cyclam)]·[FeCl(NO+)(cyclam)]2}(PF6)6 complex
  479. Metal-Induced Cyclization of Thiosemicarbazones Derived from β-Keto Amides and β-Keto Esters:  Open-Chain and Cyclized Ligands in Zinc(II) Complexes
  480. Supramolecular self-assembly in the crystal structures of methylmercury xanthates, MeHgS(S)COR, R=Et, iPr and CH2Ph
  481. Disodium pamidronate
  482. Synthesis and structure of cadmium and zinc complexes of dehydroacetic acid
  483. Epikatonic acid fromAustroplenckia populnea: structure elucidation by 2D NMR spectroscopy and X-ray crystallography
  484. Serendipitous, one-pot formation of 2,3,7-triphenylcyclopenta[c]pyran from 1,2-diphenylethanedione (“benzil”) and cyclopentadiene
  485. Structural Transition and Pair Formation inFe3
  486. 6-Deoxyjacareubin
  487. 1-(2-{4-[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiol-3-ylcarbonyl]phenoxy}ethyl)piperidinium chloride
  488. Role of the Hydrogen Bonds in Nitroanilines Aggregation:  Charge Density Study of 2-Methyl-5-nitroaniline
  489. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  490. Structure and properties of iron–cyclam complex of 2-aminophenol
  491. THE CRYSTAL STRUCTURE OF DICHLORODIPHENYLBIPYRIDINE LEAD(IV), [PbPh2Cl2(bipy)]
  492. THE CRYSTAL STRUCTURE OF DIBROMOBIPYRIDINELEAD(II), [PbBr2(bpy)]
  493. THE CRYSTAL STRUCTURE OF DICHLORODIPHENYLPHENANTHROLINELEAD(IV), [PbPh2Cl2(phen)]
  494. Crystal structure and exchange pathways of the complex l-(trypthophyl-glycinato)copper(II)
  495. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  496. Hydrogen Bonding in Nitroanilines:  Neutron Diffraction Study of m -Nitroaniline at 100 K
  497. Electrosynthesis of binuclear ruthenium complexes from [RuCl3(dppb)(L)] precursors [L = pyridine, 4-methylpyridine or dimethyl sulfoxide; dppb = 1,4-bis(diphenylphosphino)butane]
  498. Crystal structures of p-chlorobromobenzene and p-chloroiodobenzene
  499. Ba2Cu(HCOO)6, Thermal Behavior and Crystal Structure of the Room Temperature Phase
  500. Experimental evidence for the amino-group non-planarity in nitroanilines: neutron diffraction study of 2-methyl-5-nitroaniline at 100 K
  501. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  502. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  503. 2,4-Dinitro-N,N-methylphenylaniline
  504. 4-Benzyl-5-ethylthio-3H-1,2-dithiole-3-thione
  505. 2,4-Dinitrophenyl Phenyl Sulfone
  506. 4-Methyl-2-nitroaniline
  507. Structural studies of intermediates in a novel synthesis of aryloxypropiononitriles
  508. Conformational studies of substituted nitroanilines: geometry of 2-methyl-5-nitroaniline
  509. X-ray structural and spectroscopic investigation of 1-piperidine-2,4-dinitrobenzene